Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CLINICAL GENETICS

Bringing monogenic disease screening to the clinic

Nature Medicine volume 26, pages 1172–1174 (2020)Cite this article

Subjects

The Healthy Nevada Project shows that otherwise invisible disease risk can be revealed through DNA-based screening. Identifying these monogenic risks could be the first step toward a new population health-screening program.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

References

  1. Center for Disease Control and Prevention, Office of Genomics and Precision Public Health. https://www.cdc.gov/genomics/implementation/toolkit/index.htm (2014).

  2. Murray, M. F., Evans, J. P. & Khoury, M. J. J. Am. Med. Assoc. 323, 307–308 (2020).

    Article  Google Scholar 

  3. Grzymski, J.J. et al. Nat. Med. https://doi.org/10.1038/s41591-020-0982-5 (2020).

  4. Murray, M. F. Genet. Med. 18, 765–767 (2016).

    Article  CAS  Google Scholar 

  5. Biesecker, L. G. et al. Genome Res. 19, 1665–1674 (2009).

    Article  CAS  Google Scholar 

  6. Johnston, J. J. et al. Am. J. Hum. Genet. 91, 97–108 (2012).

    Article  CAS  Google Scholar 

  7. Manickam, K. et al. JAMA Netw Open. 1, e182140 (2018).

    Article  Google Scholar 

  8. Abul-Husn, N. S. et al. Genome Med. 12, 2 (2019).

    Article  Google Scholar 

  9. Manrai, A. K. et al. N. Engl. J. Med. 375, 655–665 (2016).

    Article  Google Scholar 

  10. Wilson, J. M. & Jungner, Y. G. Bol. Oficina Sanit. Panam. 65, 281–393 (1968).

    CAS  PubMed  Google Scholar 

  11. Winawer, S. J. Dig. Dis. Sci. 60, 596–608 (2015).

    Article  Google Scholar 

  12. U.S. Preventive Services Task Force. Ann. Intern. Med. 149, 627–637 (2008).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Genetics, Yale School of Medicine, New Haven, CT, USA

    Michael F. Murray

  2. Yale-New Haven Health System, New Haven, CT, USA

    Monica A. Giovanni

Authors
  1. Michael F. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monica A. Giovanni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Michael F. Murray or Monica A. Giovanni.

Ethics declarations

Competing interests

M.F.M. has received grants from Regeneron Pharmaceuticals (2014–2018) and personal fees from Invitae (scientific advisory board member 2016–2017) and 54gene (scientific advisory board member 2020).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Murray, M.F., Giovanni, M.A. Bringing monogenic disease screening to the clinic. Nat Med 26, 1172–1174 (2020). https://doi.org/10.1038/s41591-020-1017-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-020-1017-y

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing